Aditi Chatterjee Selected Research

Aditi Chatterjee Research Topics

Disease

43	Neoplasms (Cancer) 10/2023 - 10/2005
15	Squamous Cell Carcinoma of Head and Neck 01/2021 - 05/2008
8	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2005
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2013
7	Carcinogenesis 01/2021 - 10/2005
6	Adenocarcinoma 01/2022 - 06/2013
5	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020 - 04/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 04/2012
4	Mouth Neoplasms (Oral Cancer) 09/2021 - 12/2018
4	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2015
4	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 07/2006
3	Head and Neck Neoplasms (Head and Neck Cancer) 12/2018 - 02/2011
3	Infections 12/2017 - 07/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 08/2021
2	Malaria 11/2023 - 11/2022
2	Parasitemia 11/2023 - 11/2023
2	Ductal Carcinoma 10/2023 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 01/2021
2	Asthma (Bronchial Asthma) 09/2015 - 01/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2007 - 02/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2023
1	Genomic Instability 08/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2021
1	Chromosome Breakage 08/2021
1	Medulloblastoma 01/2020
1	Margins of Excision 01/2020
1	Adenocarcinoma of Lung 08/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2018
1	Esophageal Neoplasms (Esophageal Cancer) 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Mucoepidermoid Carcinoma 01/2017

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2013
17	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2005
11	SmokeIBA 01/2021 - 01/2011
9	Phosphotransferases (Kinase)IBA 01/2024 - 01/2016
7	Mitochondrial DNA (mtDNA)IBA 01/2020 - 07/2003
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 04/2012
6	Small Interfering RNA (siRNA)IBA 09/2016 - 02/2011
5	MicroRNAs (MicroRNA)IBA 10/2023 - 08/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2013
4	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 10/2005
3	Antimalarials (Antimalarial Agents)IBA 11/2023 - 11/2022
3	CytokinesIBA 12/2018 - 09/2015
3	ProteomeIBA 01/2017 - 08/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 01/2011
2	fms-Like Tyrosine Kinase 3IBA 01/2024 - 08/2021
2	artemisinin (artemisinine)IBA 11/2023 - 11/2022
2	ParaffinIBA 09/2021 - 01/2020
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 08/2006
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2013
2	Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA 01/2021 - 01/2015
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 01/2018
2	ArsenicIBA 01/2017 - 04/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2016 - 01/2013
2	PhosphotyrosineIBA 10/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 08/2014 - 06/2005
2	Protein Isoforms (Isoforms)IBA 12/2010 - 05/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2007 - 10/2006
2	GuanineIBA 10/2006 - 06/2005
1	gilteritinibIBA 01/2024
1	Complex MixturesIBA 11/2023
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 11/2021
1	CyclinsIBA 11/2021
1	EnzymesIBA 09/2021
1	Formaldehyde (Formol)FDA Link 09/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	AZD1208IBA 08/2021
1	Topoisomerase II InhibitorsIBA 08/2021
1	Doublecortin-Like KinasesIBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021
1	fedratinibIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	PanobinostatIBA 01/2021
1	STO 609IBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2020
1	VaccinesIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	HMGN2 Protein (HMGN2)IBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020
1	Proline (L-Proline)FDA Link 06/2019
1	Lobeline (Smokeless)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	protein kinase NIBA 12/2018
1	Peptides (Polypeptides)IBA 08/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2018
1	p38 Mitogen-Activated Protein KinasesIBA 12/2017
1	IsotopesIBA 01/2017
1	Amino Acids FDA Link 01/2017
1	PF 3758309IBA 09/2016
1	rottlerinIBA 01/2016
1	CurcuminIBA 01/2016
1	shikimate kinaseIBA 01/2016

Therapy/Procedure

13	Therapeutics 11/2023 - 01/2011
4	Drug Therapy (Chemotherapy) 08/2021 - 01/2011
1	Traditional Medicine (Folk Remedies) 11/2022